Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis. - Beaussant Y; Tarbi E; Nigam K; Miner S; Sager Z; Sanders JJ; Ljuslin M; Guérin B; Thambi P; Tulsky JA; Agrawal M. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer. - Thrul J; Kozak Z; Carducci MA; Garcia-Romeu A; Yaden DB. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder. - Agrawal M; Richards W; Beaussant Y; Shnayder S; Ameli R; Roddy K; Stevens N; Richards B; Schor N; Honstein H; Jenkins B; Bates M; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders - Yale University (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue. - Robinson GI; Li D; Wang B; Rahman T; Gerasymchuk M; Hudson D; Kovalchuk O; Kovalchuk I. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms. - McCulloch DE; Lopez JP; Dalla C; Castrén E; Erritzoe D; Frokjaer VG; Lundberg J; Preller KH; Fisher PM; Knudsen GM. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats. - Reinwald JR; Schmitz CN; Skorodumov I; Kuchar M; Weber-Fahr W; Spanagel R; Meinhardt MW. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms - Conn K; Milton L; Huang K; Munguba H; Ruuska J; Lemus M; Greaves E; Homman-Ludiye J; Oldfield B; Foldi C. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers. - Mathai DS; Hilbert S; Sepeda ND; Strickland JC; Griffiths RR; Garcia-Romeu A. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development. - Weintraub MJ; Jeffrey JK; Grob CS; Ichinose MC; Bergman RL; Cooper ZD; Miklowitz DJ. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions. - Brennan W; Kelman AR; Belser AB. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings. - Nicholas CR; Horton DM; Malicki J; Baltes A; Hutson PR; Brown RT. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The effect of casing and gypsum on the yield and psychoactive tryptamine content of Psilocybe cubensis (Earle) Singer. - Foster K; Morrison I; Tyler M; Delgoda R. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Statistical diversity distinguishes global states of consciousness - Starkey J; Carhart-Harris RL; Pigorini A; Nobili L; Barrett AB. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Group psychedelic therapy: empirical estimates of cost-savings and improved access. - Marseille E; Stauffer CS; Agrawal M; Thambi P; Roddy K; Mithoefer M; Bertozzi SM; Kahn JG. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Preclinical models of treatment-resistant depression: challenges and perspectives. - Kolasa M; Faron-Górecka A (Pharmacological reports: PR, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Mindfulness meditation and psychedelics: potential synergies and commonalities. - Holas P; Kamińska J (Pharmacological reports: PR, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin therapy to reduce depression following a terminal diagnosis. - Boudreau E; Orlowski K. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin's Erasure of EGO. - Ahlskog G. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations. - McTaggart AR; McLaughlin S; Slot JC; McKernan K; Appleyard C; Bartlett TL; Weinert M; Barlow C; Warne LN; Shuey LS; Drenth A; James TY. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samples. - Cardoso MS; da Cunha KF; Silva IG; Fiorentin TR; de Campos EG; Costa JL. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain. - Kolbman N; Liu T; Guzzo P; Gilligan J; Mashour GA; Vanini G; Pal D. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants. - Duan W; Cao D; Wang S; Cheng J. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials. - Wang SM; Kim S; Choi WS; Lim HK; Woo YS; Pae CU; Bahk WM. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD). - Apex Labs Ltd. (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds. - Waldbillig A; Baranova M; Neumann S; Andrade J; Sidhu S. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review. - Gattuso JJ; Wilson C; Hannan AJ; Renoir T. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

[Feeling unwell after eating a piece of chocolate]. - van der Schuur-Saleem R; Visser E; Robben H; Zwols M; den Besten-Berthololee D. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Brief Historical Overview of Psychedelic Research. - Geyer MA. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach - McAlpine R; Krajnović K; Khan M; Morometescu L; Simonsson O; Sacchet M; Kamboj S. (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Biological studies of clavine alkaloids targeting CNS receptors. - Tasker NR; Pazur EJ; Wipf P. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Drug-drug interactions involving classic psychedelics: A systematic review. - Halman A; Kong G; Sarris J; Perkins D. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders. - Raithatha SA; Hagel JM; Matinkhoo K; Yu L; Press D; Cook SG; Sharma G; Dhananjaya D; Jensen G; Lee JB; Cai C; Gallant J; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphere - McTaggart A; Scarlett K; Slot J; Barlow C; Appleyard C; Gardiner D; Fechner N; Tilden J; Hass D; Voogelbreinder S; Lording W; Lloyd R; et al. (Authorea Preprints, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics. - Hovmand OR; Poulsen ED; Arnfred S. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice. - Hernandez-Leon A; Escamilla-Orozco RI; Tabal-Robles AR; Martínez-Vargas D; Romero-Bautista L; Escamilla-Soto G; González-Romero OS; Torres-Valencia M; González-Trujano ME. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis. - Bahji A; Lunsky I; Gutierrez G; Vazquez G. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Aesthetic Chills Mitigate Maladaptive Cognition In Depression - Schoeller F; Jain A; Adrien V; Maes P; Reggente N. (Research Square, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample. - Kvam TM; Uthaug MV; Andersen KAA; Refsum BB; Tunstad PA; Stewart LH; Jacobsen HB; Grønnerød C. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential. - Raj P; Rauniyar S; Sapkale B. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The psychedelic effects of cannabis: A review of the literature. - Wolinsky D; Barrett FS; Vandrey R. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression - COMPASS Pathways (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The entropic heart: Tracking the psychedelic state via heart rate dynamics - Rosas FE; Mediano PA; Timmermann C; Luppi AI; Candia-Rivera D; Abbasi-Asl R; Gazzaley A; Kringelbach ML; Muthukumaraswamy S; Bor D; Garfinkel S; Carhart-Harris RL. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders. - Heresco-Levy U; Lerer B. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies. - Chruścicka-Smaga B; Machaczka A; Szewczyk B; Pilc A. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The possible place for psychedelics in pharmacotherapy of mental disorders. - Wojtas A. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans. - Madrid-Gambin F; Fabregat-Safont D; Gomez-Gomez A; Olesti E; Mason NL; Ramaekers JG; Pozo OJ. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney's lesions. - Iorgu AM; Vasilescu AN; Pfeiffer N; Spanagel R; Mallien AS; Inta D; Gass P. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain. - Van Der Walt J; Parker R. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports. - Žuljević MF; Mijatović A; Marušić SL; Kudrjavets G; Buljan I; Hren D. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A "Magic Mushroom" Multi-Product Sesquiterpene Synthase. - Schäfer E; Seibold PS; Bartram S; Trottmann F; Haensch VG; Gressler M; Chadeayne AR; Hertweck C; O'Connor SE; Hoffmeister D (Chembiochem: a European journal of chemical biology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders. - Rhee TG; Davoudian PA; Sanacora G; Wilkinson ST. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Cultivation, chemistry, and genome of Psilocybe zapotecorum - Miller DR; Jacobs JT; Rockefeller A; Singer H; Bollinger IM; Conway J; Slot JC; Cliffel DE. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The remarkable reimagining of psilocybin. - Filer CN. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception - Muller S; Cavanna F; de la Fuente L; Bruno N; D’Amelio TA; Pallavicini C; Tagliazucchi E. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

[Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland]. - Olafsson RP; Kvaran K; Ketilsdottir K; Hallgrimsdottir K; Sigurdsson EL; Sigurdsson E. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

[Determination of amanita peptide and tryptamine toxins in wild mushrooms by high performance liquid chromatography-tandem mass spectrometry]. - Liu LQ; Chen JZ; Fu WS; Tang CY. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury. - Gray JC; Murphy M; Carter SE; Johnson MW; Wolfgang AS; Roy MJ; Maples-Keller JL. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action. - Cameron LP; Benetatos J; Lewis V; Bonniwell EM; Jaster AM; Moliner R; Castrén E; McCorvy JD; Palner M; Aguilar-Valles A. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies. - Stocker K; Hartmann M; Ley L; Becker AM; Holze F; Liechti ME. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review. - Kaminski D; Reinert JP. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics. - Banushi B; Polito V (Biology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues - Kratina S; Lo C; Schwartz R; Strike C; Jopling S; Nayfeh A; Rush B. (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice. - Takaba R; Ibi D; Yoshida K; Hosomi E; Kawase R; Kitagawa H; Goto H; Achiwa M; Mizutani K; Maeda K; González-Maeso J; Kitagaki S; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Cardiovascular safety of psychedelic medicine: current status and future directions. - Wsół A. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms - Rakoczy RJ; Runge GN; Sen AK; Sandoval O; Nguyen Q; Roberts BR; Sciortino JH; Gibbons WJ; Friedberg LM; Andrew Jones J; McMurray MS. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test. - Rahbarnia A; Li Z; Fletcher PJ. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats. - Malikowska-Racia N; Koniewski M; Golebiowska J; Popik P. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review. - Watford T; Masood N. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use - Mathai DS; Roberts DE; Nayak SM; Sepeda ND; Lehrner A; Johnson M; Lowe MX; Jackson H; Garcia-Romeu A. (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use - Mathai DS; Roberts DE; Nayak SM; Sepeda ND; Lehrner A; Johnson M; Lowe MX; Jackson H; Garcia-Romeu A. (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences. - Rieser NM; Gubser LP; Moujaes F; Duerler P; Lewis CR; Michels L; Vollenweider FX; Preller KH. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II - Yale University (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I - Yale University (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Novel treatments for anorexia nervosa: Insights from neuroplasticity research. - Keeler JL; Kan C; Treasure J; Himmerich H. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility study - Enriquez-Geppert S; Krc J; O'Higgins F; Lietz MP. (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin-assisted therapy for depression: A systematic review and meta-analysis. - Haikazian S; Chen-Li DCJ; Johnson DE; Fancy F; Levinta A; Husain MI; Mansur RB; McIntyre RS; Rosenblat JD. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use. - Card KG; Grewal A; Closson K; Martin G; Baracaldo L; Allison S; Kruger DJ; Walsh Z. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology - Shinozuka K; Jerotic K; Mediano P; Zhao AT; Preller KH; Carhart-Harris R; Kringelbach ML. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1). - Donegan CJ; Daldegan-Bueno D; Sumner R; Menkes D; Evans W; Hoeh N; Sundram F; Reynolds L; Ponton R; Cavadino A; Smith T; Roop P; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis. - Ko K; Carter B; Cleare AJ; Rucker JJ. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results. - Linguiti S; Vogel JW; Sydnor VJ; Pines A; Wellman N; Basbaum A; Eickhoff CR; Eickhoff SB; Edwards RR; Larsen B; McKinstry-Wu A; Scott JC; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin kann offenbar Depressionen lindern. - Müller T. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANS - Vejmola Cestmir; Syrová Kateřina; Šíchová Klára; Koudelka Vlastimil; Hubený Jan; Kluckova Tereza; Nikolic Marek; Kelemen Eduard; Páleníček Tomáš (IBRO Neuroscience Reports, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis. - Gold ND; Mallard AJ; Hermann JC; Zeifman RJ; Pagni BA; Bogenschutz MP; Ross S (Journal of palliative medicine, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Use of Psychedelics for Pain: A Scoping Review. - Goel A; Rai Y; Sivadas S; Diep C; Clarke H; Shanthanna H; Ladha KS. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Neuroimaging in psychedelic drug development: past, present, and future. - Wall MB; Harding R; Zafar R; Rabiner EA; Nutt DJ; Erritzoe D. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence - University of New Mexico (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A suite of engineered mice for interrogating psychedelic drug actions - Chiu Y; Deutch AY; Wang W; Schmitz GP; Huang KL; Kocak DD; Llorach P; Bowyer K; Liu B; Sciaky N; Hua K; Chen C; et al. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Perceptions of psychedelic-assisted therapy among Black Americans. - Carter S; Packard G; Coghlan C; George JR; Brown AJ; Ching THW; Julian J; Maples-Keller JL. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala. - Kelly TJ; Bonniwell EM; Mu L; Liu X; Hu Y; Friedman V; Yu H; Su W; McCorvy JD; Liu QS. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study - Wojtas A; Bysiek A; Wawrzczak-Bargiela A; Maćkowiak M; Gołembiowska K. (Preprints.org, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic 5-HT2A receptor agonism: neuronal signatures and altered neurovascular coupling. - Padawer-Curry JA; Krentzman OJ; Kuo C; Wang X; Bice AR; Nicol GE; Snyder AZ; Siegel JS; McCall JG; Bauer AQ. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Manic episode following psilocybin use in a man with bipolar II disorder: a case report. - Halim HJ; Burk BG; Fargason RE; Birur B. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced Meditators - Milan Scheidegger (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder - University of Zurich (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the "high-risk" addiction patient. - Black T. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. - Nayak SM; Jackson H; Sepeda ND; Mathai DS; So S; Yaffe A; Zaki H; Brasher TJ; Lowe MX; Jolly DRP; Barrett FS; Griffiths RR; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness - Mortaheb S; Fort LD; Mason NL; Mallaroni P; Ramaekers JG; Demertzi A. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder. - Heinzerling KG; Sergi K; Linton M; Rich R; Youssef B; Bentancourt I; Bramen J; Siddarth P; Schwartzberg L; Kelly DF. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors. - Tyagi R; Saraf TS; Canal CE. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential. - Kargbo RB. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions - Lobe Sciences Ltd. (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin. - Bhuiya NMA; Jacobs RJ; Wang K; Sun Y; Nava B; Sampiere L; Yerubandi A; Caballero J. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter? - Pagán AF; Lex C; Soares JC; Meyer TD. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations. - Wolfgang AS; Hoge CW. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Rapid, biochemical tagging of cellular activity history in vivo - Zhang R; Anguiano M; Aarrestad IK; Lin S; Chandra J; Vadde SS; Olson DE; Kim CK. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The zebrafish for preclinical psilocybin research. - Syed OA; Tsang B; Gerlai R. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study. - Mason NL; Szabo A; Kuypers KPC; Mallaroni PA; de la Torre Fornell R; Reckweg JT; Tse DHY; Hutten NRPW; Feilding A; Ramaekers JG. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

P05-02: Assessment of the CYP450 inhibitory activity of psilocybin, psilocin, LSD, 5-MeO-DMT and mescaline: An in vitro study - Costa A.M.; Silva-Carvalho M.; Madureira-Carvalho A.; Dinis-Oliveira R.J.; Dias-da-Silva D. (Toxicology Letters, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins. - Szigeti B; Phillips LD; Nutt D (British journal of clinical pharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelics, With a Focus on Psilocybin: Issues for the Clinician. - Garakani A; Alexander JL; Sumner CR; Pine JH; Gross LS; Raison CL; Aaronson ST; Baron DA. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

History of the administration of psychedelics in France. - Dubus Z; Grandgeorge E; Verroust V. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy. - Miller M; Rosa WE; Doerner Rinaldi A; Addicott K; Spence D; Beaussant Y (Psychedelic medicine (New Rochelle, N.Y.), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats. - Kiilerich KF; Lorenz J; Scharff MB; Speth N; Brandt TG; Czurylo J; Xiong M; Jessen NS; Casado-Sainz A; Shalgunov V; Kjaerby C; Satała G; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelics for treatment resistant depression: are they game changers? - Kalfas M; Taylor RH; Tsapekos D; Young AH. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. - Raison CL; Sanacora G; Woolley J; Heinzerling K; Dunlop BW; Brown RT; Kakar R; Hassman M; Trivedi RP; Robison R; Gukasyan N; Nayak SM; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin for anorexia nervosa: If it helps, let's learn how. - Attia E; Steinglass JE. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States. - Herrmann Z; Levin AW; Cole SP; Slabaugh S; Barnett B; Penn A; Jain R; Raison C; Rajanna B; Jain S (Psychedelic medicine (New Rochelle, N.Y.), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond. - Pepe M; Hesami M; de la Cerda KA; Perreault ML; Hsiang T; Jones AMP. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin history, action and reaction: A narrative clinical review. - Sharma P; Nguyen QA; Matthews SJ; Carpenter E; Mathews DB; Patten CA; Hammond CJ. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD. - Kovacevich A; Weleff J; Claytor B; Barnett BS. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits. - Videira NB; Nair V; Paquet V; Calhoun D. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Intravenous psilocybin administration attenuates mechanical hypersensitivity in a rat model of chronic pain - Kolbman N; Liu T; Guzzo P; Gilligan JP; Mashour GA; Vanini G; Pal D. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests. - Jones G; Al-Suwaidi M; Castro-Ramirez F; McGuire TC; Mair P; Nock MK. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin desynchronizes brain networks - Siegel JS; Subramanian S; Perry D; Kay B; Gordon E; Laumann T; Reneau R; Gratton C; Horan C; Metcalf N; Chacko R; Schweiger J; et al. (medRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders. - Wong S; Yu AY; Fabiano N; Finkelstein O; Pasricha A; Jones BDM; Rosenblat JD; Blumberger DM; Mulsant BH; Husain MI. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing. - Dougherty RF; Clarke P; Atli M; Kuc J; Schlosser D; Dunlop BW; Hellerstein DJ; Aaronson ST; Zisook S; Young AH; Carhart-Harris R; Goodwin GM; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences. - Zeifman RJ; Kettner H; Pagni BA; Mallard A; Roberts DE; Erritzoe D; Ross S; Carhart-Harris RL. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics. - Abrams SK; Rabinovitch BS; Zafar R; Aziz AS; Cherup NP; McMillan DW; Nielson JL; Lewis EC. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City. - Palamar JJ; Rutherford C; Le A; Keyes KM. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study. - Cavarra M; Mason NL; Kuypers KPC; Bonnelle V; Smith WJ; Feilding A; Kryskow P; Ramaekers JG. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder. - Escamilla R; González-Trujano ME; González Mariscal JM; Torres-Valencia JM; Guzmán-González H; Vega JL; Loizaga-Velder A. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy? - Crowe M; Manuel J; Carlyle D; Lacey C. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study. - Gramling R; Bennett E; Curtis K; Richards W; Rizzo DM; Arnoldy F; Hegg L; Porter J; Honstein H; Pratt S; Tarbi E; Reblin M; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case report - Rebecchi K. (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin Pharmacokinetics - Usona Institute (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells. - Robinson GI; Li D; Wang B; Zahoruiko Y; Gerasymchuk M; Hudson D; Kovalchuk O; Kovalchuk I. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy. - Thase ME. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The risk of chronic psychedelic and MDMA microdosing for valvular heart disease. - Tagen M; Mantuani D; van Heerden L; Holstein A; Klumpers LE; Knowles R. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use. - Jones G; Herrmann F; Wang E. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Emerging Perspectives in Addiction Psychiatry. - Jordan A. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Substance use, harm reduction attitudes and behaviors among attendees of nature rave parties in Israel. - Bonny-Noach H; Shapira B; Baumol P; Tadmor N; Rosca P; Shoshan S; Harel-Fisch Y; Caduri A. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

"But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy. - Downey AE; Boyd M; Chaphekar AV; Woolley J; Raymond-Flesch M. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin-assisted psychotherapy for cancer-related anxiety and depression. - Yaniv D; Ramondetta LM; Cohen L; Amit M. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression. - Pilozzi A; Foster S; Mischoulon D; Fava M; Huang X (International journal of molecular sciences, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies. - Perez N; Langlest F; Mallet L; De Pieri M; Sentissi O; Thorens G; Seragnoli F; Zullino D; Kirschner M; Kaiser S; Solmi M; Sabé M. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Potential of Psychedelics for the Treatment of Episodic Migraine. - Schindler EAD. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia. - Mamat R; Rashid RA; Shin SM; Ibrahim B; Wahab S; Ahmad A. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice. - Jones NT; Zahid Z; Grady SM; Sultan ZW; Zheng Z; Razidlo J; Banks MI; Wenthur CJ. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022. - Jing X; Hoeh NR; Menkes DB. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin for the treatment of anorexia nervosa. - Majić T; Ehrlich S. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic drugs in the treatment of psychiatric disorders. - Ibrahim IB; Videbech P; Straszek SPV. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

On the mushrooming reports of "quiet quitting": Employees' lifetime psilocybin use predicts their overtime hours worked. - Korman BA. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study - Brain and Cognition Discovery Foundation (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance - Finkelstein C; Soha O; Roy A; Phillipou A; Rossell S. (Research Square, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients. - The Roots to Thrive Society for Psychedelic Therapy (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial. - Husain MI; Blumberger DM; Castle DJ; Ledwos N; Fellows E; Jones BDM; Ortiz A; Kloiber S; Wang W; Rosenblat JD; Mulsant BH. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study. - Peck SK; Shao S; Gruen T; Yang K; Babakanian A; Trim J; Finn DM; Kaye WH. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters. - Jahanabadi S; Amiri S; Karkeh-Abadi M; Razmi A. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis. - Simonsson O; Carlbring P; Carhart-Harris R; Davis AK; Nutt DJ; Griffiths RR; Erritzoe D; Goldberg SB. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom Extract - Shahar O; Botvinnik A; Shwartz A; Lerer E; Buko A; Hamid E; Kahn D; Guralnick M; Blakolmer K; Wolf G; Lerer L; Lerer B; et al. (Research Square, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression - Goodwin G; Marwood L; Mistry S; Nowakowska A; Simmons H; Tsai J; Williams S; Young M; Malievskaia E. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol - Husain M; Blumberger D; Castle D; Kloiber S; Ortiz A; Rosenblat J; Mulsant B. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelics for depression: from neurobiology to treatment - Kuypers K. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatment - Sousa R; Costa L; Brás J; Vaz R; Martins J; Abreu J; Almeida E; Castro N; Andrade R; Cunha N. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The therapeutic potential of psilocybin in depression resistant to psychotropic drugs - Ramírez González J; Fernández Márquez I; Ferreiro González S; Ruíz E. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A systematic review to assess the use of psilocybin in the treatment of headaches - Bhanot S; Lin M; Bains S; Monroe A; Tsang V. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression - Lin M; Lee H; Tsang V; Chai B; Howard A; Uy C; Elefante J. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin as an antidepressant strategy - a review of safety aspects - Zeiss R. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM. - Weiss B; Ginige I; Shannon L; Giribaldi B; Murphy-Beiner A; Murphy R; Baker-Jones M; Martell J; Nutt DJ; Carhart-Harris RL; Erritzoe D. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions - Brennan B; Kelman A; Belser AB. (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour - Nkadimeng SM; Hay L; Steinmann CM; Eloff JN. (Research Square, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation. - Moujaes F; Rieser NM; Phillips C; de Matos NMP; Brügger M; Dürler P; Smigielski L; Stämpfli P; Seifritz E; Vollenweider FX; Anticevic A; Preller KH. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences. - Davis AK; Timmermann C; Ortiz Bernal AM; Lancelotta R; Nayak S; Sepeda ND; Nikolaidis A; Griffiths RR. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication. - Goodwin GM; Croal M; Feifel D; Kelly JR; Marwood L; Mistry S; O'Keane V; Peck SK; Simmons H; Sisa C; Stansfield SC; Tsai J; et al. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Must Psilocybin Always "Assist Psychotherapy"? - Goodwin GM; Malievskaia E; Fonzo GA; Nemeroff CB. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics. - Nogrady B. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study. - Więckiewicz G; Stokłosa I; Stokłosa M; Więckiewicz W; Gorczyca P; Gondek TM. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models - Chernoff T; Kliger B; Venturini DH. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice - Takaba R; Ibi D; Yoshida K; Hosomi E; Kawase R; Kitagawa H; Goto H; Achiwa M; Mizutani K; Maede K; González-Maeso J; Kitagaki S; et al. (Research Square, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin - Tetem J; Fischmann T; Möller TJ. (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD) - Cybin Therapeutics Inc. (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review. - Hovmand OR; Poulsen ED; Arnfred S; Storebø OJ. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Navigating the chaos of psychedelic fMRI brain-entropy via multi-metric evaluations of acute psilocybin effects - McCulloch DE; Olsen AS; Ozenne B; Stenbaek DS; Armand S; Madsen MK; Knudsen GM; Fisher PM. (medRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin's effects on cognition and creativity: A scoping review. - Bonnieux JN; VanderZwaag B; Premji Z; Garcia-Romeu A; Garcia-Barrera MA. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first. - Haridy R. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Serotonin 5-HT2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents. - McIntyre RS. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents. - McIntyre RS. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Adapting psychedelic medicine for headache and chronic pain disorders. - Schindler EAD; Hendricks PS. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Assessing potential of psilocybin for depressive disorders. - Kozak Z; Johnson MW; Aaronson ST. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report. - Lawrence DW. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study - Gwyther M; Aspell JE. (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives. - Jachimowski A; Kucia K. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms. - Skosnik PD; Sloshower J; Safi-Aghdam H; Pathania S; Syed S; Pittman B; D'Souza DC. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Clinical specificity profile for novel rapid acting antidepressant drugs. - Scala M; Fanelli G; De Ronchi D; Serretti A; Fabbri C. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder - Halucenex Life Sciences Inc. (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective. - De La Haye W; Walcott G; Eaton J; Beckford J; Greene J. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review. - Lee HJ; Tsang VW; Chai BS; Lin MC; Howard A; Uy C; Elefante JO. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin: The most effective moral bio-enhancer? - Rakić V. (2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com